During the past decade, California Hematology/Oncology Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "California Hematology/Oncology Medical Group" are "Lung Cancer" (2 trials), "Liver Cancer" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "California Hematology/Oncology Medical Group" in a lesser frequency.

Most popular intervention types in "California Hematology/Oncology Medical Group" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel poliglumex" (2 trials), "Gemzar (Gemcitabine)" (1 trials), "SGN-15 (cBR96-Doxorubicin Immunoconjugate)" (1 trials), "carboplatin" (1 trials) and "docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "California Hematology/Oncology Medical Group" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "California Hematology/Oncology Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in California Hematology/Oncology Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in California Hematology/Oncology Medical Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".